Navigation Links
InterMune Reports First Quarter 2009 Financial Results and Business Highlights
Date:4/30/2009

eriodic reports filed with the SEC, all of which are available via InterMune's web site at www.intermune.com.

Actimmune(R) is a registered trademark of InterMune, Inc. Pegasys(R) and Copegus(R) are registered trademarks of Roche.

Financial tables follow

                                   InterMune, Inc.
             PRELIMINARY CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
                 (unaudited, in thousands, except per share amounts)

                                                           Three Months Ended
                                                                 Mar 31
                                                                 ------
                                                           2009          2008*
                                                           ----          ----
      Revenue, net
        Actimmune                                        $6,032        $8,496
        Collaboration revenue                               818           818
                                                            ---           ---
          Total revenue, net                              6,850         9,314

      Costs and expenses:
        Cost of goods sold                                2,858         3,186
        Research and development                         24,427        27,181
        General and administrative                        8,476         7,467
        Acquired research and development milestone      13,500             -
        Restructuring charges                               613             -
                                                            ---           ---
          Total costs and expenses                       49,874        37,834

      Loss from operations                              (43,024)      (28,520)

      Interest income       
'/>"/>
SOURCE  InterMune, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 

Related biology technology :

1. InterMune to Release First Quarter Financial Results on April 30
2. InterMune and Pharmasset to Discuss INFORM-1 Results From EASL Conference, April 25
3. InterMune to Present at Canaccord Adams Hepatitis C Conference
4. InterMune to Present at Citis 4th Annual Biotech Day
5. InterMune to Present Abstracts on HCV Protease Inhibitor ITMN-191 and HCV Development Program at the EASL Meeting
6. InterMune Reports Fourth Quarter and Full Year 2008 Financial Results and Business Highlights
7. InterMune to Release Fourth Quarter, Full Year 2008 Financial Results on February 26
8. InterMune Announces Issuance of U.S. Patent for ITMN-191
9. InterMune Announces Pricing of Public Offering of 3,500,000 Shares of Common Stock
10. InterMune Reports Results of Two Phase 3 CAPACITY Studies of Pirfenidone in IPF
11. InterMune to Present at J.P. Morgan Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/16/2013)... 16, 2013 As the weather warms, women ... favorite Spring looks. While most make a statement with fashion, ... women find the warmer weather mixes makeup and sweat to ... the onset of acne during warmer months, Adult Acne ... treatment users the best ways to deter breakouts. , ...
(Date:5/16/2013)... , May 16, 2013 /PRNewswire/ ... market research report is available in ... Competitor Analysis: Therapeutic Proteins ... http://www.reportlinker.com/p01171947/Competitor-Analysis-Therapeutic-Proteins-–-Biosimilars-Biobetters--Biosuperiors.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Biopharmaceutical   ...   The new Competitive ...
(Date:5/16/2013)... Arlington, VA (PRWEB) May 16, 2013 ... for Primary Cells & Stem Cell-Derived Cells: Current and ... low, the number of suppliers in the primary cells ... examines what cell types are used most often, how ... is the market size and anticipated growth rate. ...
(Date:5/16/2013)... Stephen Y. Chou, Founder of Nanonex Corporation, will be ... IEEE Nano 2013 in Beijing, China, on August 5th ... becoming one of the most critical nanofabrication technologies today ... large area, and low cost unmatchable by other nanofabrication ... a broad range of industries, from ICs, nano/micro optical ...
Breaking Biology Technology:Adult Acne Treatment, Probiotic Action Shares New Tips for Women on How to Fight Acne While Wearing Makeup 2Competitor Analysis: Therapeutic Proteins - Biosimilars, Biobetters & Biosuperiors 2Competitor Analysis: Therapeutic Proteins - Biosimilars, Biobetters & Biosuperiors 3Competitor Analysis: Therapeutic Proteins - Biosimilars, Biobetters & Biosuperiors 4Competitor Analysis: Therapeutic Proteins - Biosimilars, Biobetters & Biosuperiors 5Competitor Analysis: Therapeutic Proteins - Biosimilars, Biobetters & Biosuperiors 6Competitor Analysis: Therapeutic Proteins - Biosimilars, Biobetters & Biosuperiors 7Competitor Analysis: Therapeutic Proteins - Biosimilars, Biobetters & Biosuperiors 8BioInformatics LLC New Market Report – The Market for Primary Cells & Stem Cell-Derived Cells: Current and Future Opportunities (13-004) 2BioInformatics LLC New Market Report – The Market for Primary Cells & Stem Cell-Derived Cells: Current and Future Opportunities (13-004) 3Founder, Prof. Stephen Chou to Give Tutorial on Nanoimprint at IEEE Nano 2013 2
... Inc.,(Nasdaq CM: INSM), a developer of follow-on biologics ... the,Company has retained the services of RBC Capital ... "Insmed,s Board of Directors and senior management ... be utilizing RBC,s experience and,expertise to examine a ...
... (http://www.amdl.com ) AMDL,Inc., (Amex: ADL ) a leading ... the US, announced that the,AMDL-ELISA DR- 70(R) (FDP) test ... the,detection of cancer in clinical practice according to an ... at the University Hospital,in Frankfurt Germany. The results were ...
... 11 Bioheart, Inc.,(Nasdaq: BHRT ) ... and,biologics that help monitor, diagnose and treat ... Doug Owens, Director,Clinical Affairs, will assume responsibility ... investigational MyoCell(R) Therapy clinical,trials from Richard T. ...
Cached Biology Technology:Insmed Retains RBC Capital Markets as Strategic Financial Advisor 2Insmed Retains RBC Capital Markets as Strategic Financial Advisor 3AMDL ELISA DR-70(R) (FDP) is Promising as Effective Cancer Detection Test 2AMDL ELISA DR-70(R) (FDP) is Promising as Effective Cancer Detection Test 3Bioheart, Inc., Announces Management Change 2Bioheart, Inc., Announces Management Change 3
(Date:5/17/2013)... May 17, 2013, Shenzhen, China---- Why Tibetan antelope ... Qinghai-Tibetan Plateau? In a collaborative research published in ... BGI, and other institutes provide evidence that some ... adaption to harsh highland environments. The data in ... specific genetic mechanisms and the biology of other ...
(Date:5/17/2013)... international team of scientists using a new X-ray method ... living frog embryo in greater detail than ever before., ... research and the search for new treatments for genetic ... fr Technologie in Germany, in collaboration with the Advanced ... National Laboratory, released the most precise depiction ever of ...
(Date:5/16/2013)... HOUSTON African-American adults living closer to a fast ... than those who lived further away from fast food, ... Anderson Cancer Center, and this association was particularly strong ... new study published online in the American Journal ... residential proximity to a fast food restaurant, and among ...
Breaking Biology News(10 mins):The genome sequence of Tibetan antelope sheds new light on high-altitude adaptation 2New X-ray method shows how frog embryos could help thwart disease 2Body mass index of low income African-Americans linked to proximity of fast food restaurants 2Body mass index of low income African-Americans linked to proximity of fast food restaurants 3
... study by scientists at the University of Miami (UM) Rosenstiel ... to estimate how much of the ocean,s pollution is falling ... understanding of how toxic airborne chemicals, from the burning of ... oceans globally. By measuring Beryllium-7 (7Be) isotope concentrations ...
... PORTLAND, Ore. Researchers at Oregon Health & Science ... for a kind of cancer called sarcoma. In a study ... Cancer Cell , they report that childhood and adult sarcomas ... which these tumors first start. These findings may lead to ...
... of deadly hantavirus outbreaks in people can be predicted months ... in vegetation that boost mouse populations, a University of Utah ... rodent-borne illnesses worldwide. "It,s a way to remotely track ... all the time," says Denise Dearing, professor of biology at ...
Cached Biology News:University of Miami scientists find new way to estimate global rainfall and track ocean pollution 2Scientists discover cell of origin for childhood muscle cancer 2Monitoring killer mice from space 2Monitoring killer mice from space 3Monitoring killer mice from space 4Monitoring killer mice from space 5
...
Full-length cDNA 5-PRIME end of clone CS0DE013YM09 of Placenta of Homo sapiens (human). [Source:Uniprot/SPTREMBL;Acc:Q86TS7] Antigen: Recombinant Protein Epitope Signature Tag (PrEST)....
5(S)-HETE-d8 is used as an internal standard for the quantification of 5(S)-HETE by stable isotope dilution mass spectrometry....
... atoms at the 9, 10, 12, and 13 ... internal standard for the quantification of 9(S)-HODE by ... the lipoxygenation of linoleic acid in both plants ... plaques, as an esterified component of membrane phospholipids ...
Biology Products: